Catalyst Pharmaceuticals (CPRX) Stock Highlights

21.27 | -0.89%

2024-12-21 03:07:18

Catalyst Pharmaceuticals Inc is a biopharmaceutical company. It focuses on developing and commercializing innovative therapies for people with rare, debilitating, chronic neuromuscular and neurological diseases. It offers Firdapse, a proprietary form of amifampridine phosphate for the treatment of patients with Lambert-Eaton myasthenic syndrome.

Statistics

Range Today

21.01 21.41

Volume Today 1.75M

Range 1 Year

13.12 24.27

Volume 1 Year 294.14M

Range 3 Year

5.24 24.27

Volume 3 Year 1.22B

Range 10 Year

0.51 24.27

Volume 10 Year 3.47B

Highlights

Market Capitalization 2.85B (mid)

Floating Shares 102.94M

Current Price 21.27

Price To Earnings 19.26

Price To Revenue 5.25

Price To Book 4.32

Earnings Per Share 1.22

Payout Ratio 0%

Performance

Latest -0.89%

1 Month -1.16%

3 Months -0.75%

6 Months +42.94%

1 Year +44.79%

3 Years +208.71%

5 Years +413.77%

10 Years +635.99%

Benchmarks

Market Capitalization

91 / 368

Gross Profits

38 / 278

Total Revenue

33 / 300

Total Rank

78 / 368

Free Cashflow

327 / 352

Performance 5 years

18 / 368

Obligatory risk notice

We would like to point out that the contents of this website are for general information purposes only and do not constitute recommendations for the purchase or sale of specific financial instruments, and therefore do not constitute investment advice. In particular, marketstorylabs.com and its creators cannot assess the extent to which information / recommendations made on the pages correspond to your investment objectives, your risk tolerance and your ability to bear losses. Therefore, if you make any investment decisions based on information on the site, you do so solely on your own responsibility and at your own risk. This in turn means that neither marketstorylabs.com nor its creators are liable for any losses incurred as a result of investment decisions based on the information on the marketstorylabs.com website or other media used.